Upgrade to SI Premium - Free Trial

Xeris Pharmaceuticals Inc. (XERS)

7.57 +0.12 (1.61%)

Chart
Today 6M 1Y 5Y

Upcoming Events

- Earnings (11/5/26)

Latest Headlines

Oppenheimer Reiterates Outperform Rating on Xeris Pharmaceuticals (XERS) September 10, 2026 6:11 AM - StreetInsider Xeris Announces Details for XP-8121 Program Overview Webinar August 26, 2026 7:30 AM - BizWire Form 4 Xeris Biopharma Holdings For: Aug 01 Filed by: Shannon John Patrick Jr August 21, 2026 4:23 PM - SEC Filing Form 4 Xeris Biopharma Holdings For: Aug 01 Filed by: McCulloch Kevin August 21, 2026 4:16 PM - SEC Filing Form 4 Xeris Biopharma Holdings For: Aug 12 Filed by: Pieper Steven August 12, 2026 4:45 PM - SEC Filing Form 144 Xeris Biopharma Holdings Filed by: Pieper Steven August 12, 2026 4:38 PM - SEC Filing Form 10-Q Xeris Biopharma Holdings For: Jun 30 August 6, 2026 4:11 PM - SEC Filing Form 8-K Xeris Biopharma Holdings For: Aug 06 August 6, 2026 7:13 AM - SEC Filing Xeris Pharmaceuticals Inc. (XERS) Misses Q2 EPS by 19c; Offers Guidance August 6, 2026 7:09 AM - StreetInsider Xeris Biopharma Reports Second Quarter 2026 Financial Results August 6, 2026 7:00 AM - BizWire Form 4 Xeris Biopharma Holdings For: Aug 03 Filed by: McCulloch Kevin August 4, 2026 5:30 PM - SEC Filing Form 4 Xeris Biopharma Holdings For: Aug 03 Filed by: Hecht Beth August 4, 2026 5:16 PM - SEC Filing Form SCHEDULE 13G Xeris Biopharma Holdings Filed by: VANGUARD CAPITAL MANAGEMENT LLC July 31, 2026 10:42 AM - SEC Filing Xeris Biopharma to Report Second Quarter 2026 Financial Results on August 6, 2026 July 23, 2026 7:30 AM - BizWire Form 8-K Xeris Biopharma Holdings For: Jul 15 July 17, 2026 4:21 PM - SEC Filing Form 4 Xeris Biopharma Holdings For: Jul 06 Filed by: Pieper Steven July 7, 2026 5:11 PM - SEC Filing Form 144 Xeris Biopharma Holdings Filed by: Pieper Steven July 7, 2026 4:38 PM - SEC Filing Form 144 Xeris Biopharma Holdings Filed by: Pieper Steven July 6, 2026 4:39 PM - SEC Filing CORRECTING and REPLACING Xeris Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4) July 2, 2026 10:40 PM - BizWire Form 4 Xeris Biopharma Holdings For: Jul 01 Filed by: KREHER NERISSA July 2, 2026 6:02 PM - SEC Filing Form 3 Xeris Biopharma Holdings For: Jul 01 Filed by: KREHER NERISSA July 2, 2026 6:00 PM - SEC Filing Form 4 Xeris Biopharma Holdings For: Jul 01 Filed by: McCulloch Kevin July 2, 2026 4:41 PM - SEC Filing Form 4 Xeris Biopharma Holdings For: Jul 01 Filed by: Hecht Beth July 2, 2026 4:39 PM - SEC Filing Xeris Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4) July 2, 2026 4:05 PM - BizWire Form 144 Xeris Biopharma Holdings Filed by: Hecht Beth July 1, 2026 4:51 PM - SEC Filing Form 144 Xeris Biopharma Holdings Filed by: McCulloch Kevin July 1, 2026 4:21 PM - SEC Filing Form 8-K Xeris Biopharma Holdings For: Jun 29 June 30, 2026 4:07 PM - SEC Filing Xeris names CEO John Shannon as board chair, adds new director June 30, 2026 7:00 AM - StreetInsider Xeris Announces Updates to Its Board of Directors June 30, 2026 7:00 AM - BizWire Full Article List